Paper38245646
Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
Xiao X and 8 others. Ann Surg Oncol, 2024. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation. Papers, record 38245646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38245646
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sarcopenia | Major topic |
| Esophageal Neoplasms | Major topic |
| Neoadjuvant Therapy | Major topic |
| Muscle, Skeletal | Major topic |
| Esophagectomy | Major topic |
| Humans | |
| Male | |
| Female | |
| Retrospective Studies | |
| Middle Aged | |
| Survival Rate | |
| Prognosis | |
| Aged | |
| Follow-Up Studies | |
| Chemoradiotherapy | |
| Postoperative Complications | |
| Chemoradiotherapy, Adjuvant |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022YFS0048 | Sichuan Science and Technology Program | PubMed | ||
| 81970481 | National Natural Science Foundation of China | PubMed | ||
| 2020HXFH047 | 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University | PubMed | ||
| 20HXJS005 | 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35074509 | The development and progress of nanomedicine for esophageal cancer diagnosis and treatment. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35074509 | PubMed |
| 2 | 31319389 | Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2019 | https://conductscience.org/library/papers/31319389 | PubMed |
| 3 | 33423121 | The Impact of Pretherapeutic Naples Prognostic Score on Survival in Patients with Locally Advanced Esophageal Cancer. | Ann Surg Oncol | 2021 | https://conductscience.org/library/papers/33423121 | PubMed |
| 4 | 26416715 | Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. | Ann Surg Oncol | 2016 | https://conductscience.org/library/papers/26416715 | PubMed |
| 5 | 34664431 | Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. | J Cachexia Sarcopenia Muscle | 2021 | https://conductscience.org/library/papers/34664431 | PubMed |
| 6 | 35794004 | Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis. | Ann Surg | 2022 | https://conductscience.org/library/papers/35794004 | PubMed |
| 7 | 33876359 | Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy. | Ann Surg Oncol | 2021 | https://conductscience.org/library/papers/33876359 | PubMed |
| 8 | 28796017 | Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer. | Ann Surg | 2017 | https://conductscience.org/library/papers/28796017 | PubMed |
| 9 | 28437312 | Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer. | Ann Surg | 2018 | https://conductscience.org/library/papers/28437312 | PubMed |
| 10 | 29488065 | Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis? | World J Surg | 2018 | https://conductscience.org/library/papers/29488065 | PubMed |
| 11 | 28024944 | Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. | Eur J Surg Oncol | 2017 | https://conductscience.org/library/papers/28024944 | PubMed |
| 12 | 32014971 | Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy. | Anticancer Res | 2020 | https://conductscience.org/library/papers/32014971 | PubMed |
| 13 | 25893413 | Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. | Ann Surg Oncol | 2015 | https://conductscience.org/library/papers/25893413 | PubMed |
| 14 | 31309328 | Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy. | Surg Today | 2019 | https://conductscience.org/library/papers/31309328 | PubMed |
| 15 | 29433514 | Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. | World J Surg Oncol | 2018 | https://conductscience.org/library/papers/29433514 | PubMed |
| 16 | 28861809 | Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer. | Ann Surg Oncol | 2017 | https://conductscience.org/library/papers/28861809 | PubMed |
| 17 | 27920002 | Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer. | Anticancer Res | 2016 | https://conductscience.org/library/papers/27920002 | PubMed |
| 18 | 18539529 | Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. | Lancet Oncol | 2008 | https://conductscience.org/library/papers/18539529 | PubMed |
| 19 | 18923576 | A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. | Appl Physiol Nutr Metab | 2008 | https://conductscience.org/library/papers/18923576 | PubMed |
| 20 | 15273542 | Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. | Ann Surg | 2004 | https://conductscience.org/library/papers/15273542 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42581617 | Prediction of Overall Survival in Patients With Oesophageal Cancer Using AI-Based 3D CT Body Composition Analysis. | J Cachexia Sarcopenia Muscle | 2026 | https://conductscience.org/library/papers/42581617 | PubMed |
| 42251209 | Prognostic Significance of the T12-SMI Before and After Neoadjuvant Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42251209 | PubMed |
| 42169887 | Sarcopenia in esophageal cancer: from passive prognostic marker to active treatment target. | J Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42169887 | PubMed |
| 41816377 | Assessing the prognostic impact of body composition phenotypes on surgical outcomes in patients with acute type A aortic dissection. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/41816377 | PubMed |
| 41521251 | Sarcopenia, myosteatosis and systemic immunoinflammatory index in the prediction of survival in patients undergoing immunotherapy for esophageal cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/41521251 | PubMed |
| 41019539 | Impact of skeletal muscle loss and sarcopenia on outcomes of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. | Front Nutr | 2025 | https://conductscience.org/library/papers/41019539 | PubMed |
| 40760116 | Body components at T12/L3 on CT and correlation with survival in esophageal cancer. | Eur Radiol | 2026 | https://conductscience.org/library/papers/40760116 | PubMed |
| 40607020 | Machine learning and the nomogram as the accurate tools for predicting postoperative malnutrition risk in esophageal cancer patients. | Front Nutr | 2025 | https://conductscience.org/library/papers/40607020 | PubMed |
| 40400988 | Computed tomography-based body composition and systemic inflammation for outcome prediction in patients with resectable esophageal squamous cell carcinoma. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/40400988 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38245646
GET https://conductscience.org/api/papers/v1/38245646/references?page=2